Cyclerion's sGC stimulator praliciguat ameliorates NASH in rodents

DISEASE CATEGORY: Hepatic

INDICATION: Non-alcoholic steatohepatitis (NASH)

Rat and mouse studies suggest the systemic sGC stimulator praliciguat could help treat NASH. In liver samples

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE